Subventions actuelles

Avec nos partenaires, nous nous attaquons à des problèmes concrets et nous nous engageons à construire un avenir meilleur pour tous !

En effet, en tant que centre de recherche de référence dans le domaine des sciences de la vie, nous dirigeons en permanence des projets de recherche appliquée passionnants qui visent à développer des technologies, des produits ou des services innovants, en collaboration avec des partenaires régionaux et internationaux, et nous y participons également.

Vous trouverez ci-dessous une liste des subventions actuelles auxquelles le CER Groupe participe :

• Optymevax - Win4DOC : 27/06/2022 - 27/06/2026

In silico design and development of optimized versions of key enzymes involved in the production of RNA vaccines

• NEMO - BioWIN : 01/10/2023 - 30/09/2025

New-Biological-Entity End-to-end Modeling and Optimization

• CoZyme - COST : 01/01/2023 - 31/12/2026

Establishing a Pan-European Network on Computational Redesign of Enzymes

• Multichip - Eurostars : 01/05/2023 - 30/04/2026

Rapid automated multiplex laboratory diagnostics for autoimmune diseases

• Safety Assessment of Novel Foods and Nutrient Sources - Framework Partn. Agreem. : 01/01/2023 - 31/12/2026

Support to EFSA in the Safety Assessment of Novel Foods and Nutrient Sources

• FoodWal /Peptiboost - Win4Excellence : 01/01/2023 - 31/12/2026

Bioactive peptides formulated as protein hydrolysates applicable in human and animal health

• Wal-bioimaging - FEDER : 01/07/2023 - 31/12/2025

Creation of a coordinated network of imaging technology platforms involving universities and accredited research centres.

• PEPVac - FEDER : 01/07/2023 - 31/12/2025

Setting up an innovative platform for the preclinical evaluation of new vaccine candidates and risk factors, based on a strengthened partnership between universities and accredited research centres.

• WalProt - FEDER : 01/09/2023 - 31/12/2025

Development of new avenues for valorizing plant and alternative proteins for the human food sector

• Ensured - SPF : 01/09/2023 - 01/01/2026

New open strategy for impurity surveillance of commercial microbial fermentation food products: Food supplements and vitamins as proof of concept

• Phenix - FEDER : 01/011/2023 - 30/10/2025

Plateformes technologiques et analytiques d’excellence wallonne en agro-alimentaire

• Passport - Win4Collective : 01/12/2023 - 31/12/2025

Plasma surface modification of functional implants for more effective tissue regeneration

• Phenix /GosBooster - FEDER : 01/11/2023 - 31/12/2025

Improvement of muco-adhesive properties of probiotics

• Phenix / NglycBooster - FEDER : 01/11/2023 - 31/12/2025

Development of new HMO-like preparations

• Phenix / FosBooster - FEDER : 01/11/2023 - 31/12/2025

Fine molecular characterisation of prebiotics

• MicroMIC - Win4Collective : 01/01/2024 - 31/12/2025

Microfluidics for Metabolomics

• SOLIT - Competitivity Pole : 01/01/2024 - 31/12/2026

Development of an innovative platform for highly specific tumor suppressive agents delivered by an allogenic cell-derived platform

• Hybrid-TX - Competitivity Pole : 01/01/2024 - 31/12/2026

Development of a hybrid approach comprising a viral vector and an mRNA vector for the development of a personalised cancer treatment solution